BCHE and cancer: Indeed, one study reported increased BChE levels in the serum of patients with cancers of various tissue origins following treatment, compared to baseline levels or healthy controls [45].Our findings suggest that screening current cytotoxic agents for their susceptibility to BChE metabolism is warranted, to identify compounds that are not metabolized by BChE and may therefore be more effective under these conditions.